Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy.
Kapadia, S R
Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy. [electronic resource] - Stroke Oct 2001 - 2328-32 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
1524-4628
10.1161/hs1001.096003 doi
Abciximab
Adjuvants, Pharmaceutic--therapeutic use
Aged
Antibodies, Monoclonal--adverse effects
Blood Vessel Prosthesis Implantation--adverse effects
Carotid Artery Diseases--surgery
Female
Graft Occlusion, Vascular--etiology
Humans
Immunoglobulin Fab Fragments--adverse effects
Intracranial Hemorrhages--etiology
Male
Platelet Aggregation Inhibitors--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Risk Assessment
Risk Factors
Stents--adverse effects
Thromboembolism--etiology
Treatment Outcome
Urokinase-Type Plasminogen Activator--therapeutic use
Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy. [electronic resource] - Stroke Oct 2001 - 2328-32 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
1524-4628
10.1161/hs1001.096003 doi
Abciximab
Adjuvants, Pharmaceutic--therapeutic use
Aged
Antibodies, Monoclonal--adverse effects
Blood Vessel Prosthesis Implantation--adverse effects
Carotid Artery Diseases--surgery
Female
Graft Occlusion, Vascular--etiology
Humans
Immunoglobulin Fab Fragments--adverse effects
Intracranial Hemorrhages--etiology
Male
Platelet Aggregation Inhibitors--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Risk Assessment
Risk Factors
Stents--adverse effects
Thromboembolism--etiology
Treatment Outcome
Urokinase-Type Plasminogen Activator--therapeutic use